NEW YORK (AP) Shares of BioSante Pharmaceuticals Inc. surged Thursday after regulators approved a testosterone gel that will be marketed by its partner Teva Pharmaceutical Industries Ltd. THE SPARK: The Food and Drug Administration approved Bio-T-Gel as a treatment for low testoster ...

guest published in:02-22   reply:0   view:30    last updated:02-22 19:29( guest )